Colorectal Cancer Drugs Market Size 2012-2016 and Forecast 2017-2023
A sample of this report is available upon request @
The global colorectal cancer drugs market is segmented by therapy, drug class, distribution channel, and regions.
On the basis of therapy, global colorectal cancer drugs market is segmented as
• Adjuvant chemotherapy
• Palliative chemotherapy
• Immuno therapy
• Neo adjuvant chemotherapy
On the basis of drug class, global colorectal cancer drugs market is segmented as
• Capecitabine (Xeloda)
• Irinotecan (Camptosar)
• Fluorouracil (5-FU, Adrucil)
• Trifluridine/tipiracil (TAS-102, Lonsurf)
• Oxaliplatin (Eloxatin)
Some common treatment regimens using these drugs include:
• Capecitabine, an oral form of 5-FU
• 5-FU with leucovorin (Wellcovorin), a vitamin that improves the effectiveness of 5-FU
• FOLFIRI: 5-FU with leucovorin and irinotecan
• FOLFOX: 5-FU with leucovorin and oxaliplatin
• Irinotecan alone
• XELOX/CAPEOX: Capecitabine with oxaliplatin
• XELIRI/CAPIRI: Capecitabine with irinotecan
On the basis of distribution channel, the global colorectal cancer drugs market is segmented as
• Retail Pharmacies
• Hospital Pharmacies
To view TOC of this report is available upon request @
Colorectal cancer is the third most common cancer in the world. Huge government initiatives taken by the nations are booming up the growth of the colorectal cancer drugs treatment market globally. Biologics such as Zaltrap (Ziv-Aflibercept), Erbitux (Cetuximab), Avastin (Bevacizumab) are using rapidly for the treatment for colorectal cancer that are used as a targeted therapy and they acts only on the malignant cells. Market players in the colorectal cancer drugs market forming strategic alliances and partnerships to increase their market share.
Geographically, global colorectal cancer treatment market is segmented into five key regions such as Latin America, North America, Asia-Pacific, Europe and The Middle East and Africa. North America expected to grow at significant rate in colorectal cancer drugs market owing to the growing incidence of colorectal cancer and widespread awareness about early diagnosis and treatment of colorectal cancer. Asia Pacific region expected to have rapid growth in the market during the forecast period owing to huge population densities and high incidence of colorectal cancer in countries such as India and China.
Need more information about this report @
Some of the players in the colorectal cancer drugs market are Amgen Inc. (U.S), Bristol-Myers Squibb Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bayer AG (Germany), Merck & Co., Inc. (U.S.), and Sanofi (France) to name a few.
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
152 – 160 City Road,
London EC1V 2NX
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colorectal Cancer Drugs Market Size 2012-2016 and Forecast 2017-2023 here
News-ID: 1035609 • Views: 252
More Releases from Precision Business Insights
Clinical Trials Market Share, Trends, Competitor Analysis and Forecast to 2019-2 …
Analyst Speak: “The Global Clinical Trials Market is expected to reach US$ 69.1 Bn by 2025 due to growing occurrences of life threatening diseases and technological advancements in the field of drug discovery” The global clinical trials market is expected to reach US$ 69.1 Bn by 2025. Clinical trials are experiments or observations done in clinical research to generate data on safety and efficacy. Clinical trials are done on vaccines, drugs,
Diabetes Care Devices Market is Expected to Reach US$ 24,368.4 Mn by 2025
Analyst Speak: “The Diabetes Care Devices Market is increasing at significant CAGR over the forecast period 2019-2025 and expected to reach US$ 24,368.4 Mn by 2025, due to rise in prevalence of diabetes in various countries around the world”. Precision Business Insights (PBI) in its report titled “Diabetes Care Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period
Carbon Fiber Prepreg Market Opportunities, Size, Share, Key Players, and Regiona …
The Global Carbon Fiber Prepreg Market poised to reach US$ XX Mn by 2025 with a significant CAGR over seven years forecast period 2019-2025 owing to the increasing demand from various industries. Precision Business Insights (PBI) in its report titled “Global Carbon Fiber Prepreg Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025.
Global Insulation Coatings Market Growth, Trends, Analysis, Segmentation, Foreca …
Precision Business Insights (PBI) in its report titled “Global Insulation Coating Material Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Global Insulation Coating Material Market
More Releases for Colorectal
Colorectal Cancer Market Development Trends and Growth Opportunities Till 2022
Worldwide Market Reports added Latest Research Report titled "Global Colorectal Cancer Market by Manufacturers, Regions, Product Type and Application, Forecast to 2022" to its Large Report database. Colorectal Cancer Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany,
Colorectal Cancer Drug Development Pipeline Review, 2017
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer Drug Development Pipeline Review, 2017 to its growing collection of premium market research reports. Summary This report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects. Anal cancer starts in the anus.
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @ https://goo.gl/1HQ4Fn . Report Description: Pharmaceutical guide Colorectal Cancer - Pipeline Review H1
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which